USPTO 2015–2025 USPTO PatentsView Foreign Corporation

SES-imagotag

USPTO PatentsView assignee record - 31 granted patents across 15 technology areas, recorded in grant years 2018–2024. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: G09G (Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information).

RSS updates for this company

The verdict

According to USPTO PatentsView, Ses-imagotag ranks #10,172 of 49,997 tracked US assignees by granted-patent volume, with 31 patents across 15 technology areas.

#10,172
of 49,997 US assignees by volume
Top 37%
by Innovation Score (39.8/100)
11.6
avg claims per patent
+243%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R10172 · Foreign Corporation #10,172 · 31 grants

GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL

  • GRANTS-SMALL 31 grants
  • UPPER-Q #10,172/49,997
  • PHOTO-FINISH Samyang Biopharmaceu…
  • CPC-FOCUS G09G · 15 areas
  • INNOV-THIN 39.8/100
  • CLAIMS-PAR 11.6 claims/avg
  • TYPE-FRNCORP Foreign Corp
  • VEL-SURGE +243% vel
  • BOOK-FULL 10/10 fields

Nearest grant-volume peer: Samyang Biopharmaceuticals Corporation (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

How Ses-imagotag’s 39.8 Innovation Score adds up

The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.

Innovation-score neighbourhood around Ses-imagotag

Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.

score

What this shows Ses-imagotag's Innovation Score is 39.8/100 (top 37% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Source USPTO PatentsView, PlainPatent Innovation Score As of 2015–2025

Does more volume mean deeper claims for Ses-imagotag?

Each dot is one of Ses-imagotag’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Ses-imagotag’s own 11.6 claims/patent is at or below the 11.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.

Ses-imagotag vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView. 2×2 strategic matrix plotting 9 entities by Granted patents (volume) (X) and Avg claims / patent (Y), with a crosshair dividing the plot into four quadrants. Volume + depthSelective & thoroughVolume over depthLean filer 30.93131.1 010203040 Granted patents (volume) Avg claims / patent Samyang Biopharmaceuticals Corporation - 31, 11.71Samyang Biopharma…SAN Fang Chemical Industry Co., Ltd. - 31, 7.9SAN Fang Chemical…Scion Neurostim, Inc. - 31, 30.06Scion NeurostimSennco Solutions Inc. - 31, 18.32Sennco SolutionsShenzhen Capchem Technology Co., Ltd. - 31, 11.84Shenzhen Capchem…Shenzhen Intellifusion Technologies Co., Ltd. - 31, 9Shenzhen Intellif…Shenzhen Xingrisheng Industrial Co., Ltd. - 31, 5.61Shenzhen Xingrish…Siemens Energy AS - 31, 15.26Siemens Energy ASSES-imagotag - 31, 11.61Ses-imagotag
Ses-imagotag vs its 8 nearest volume peers: granted patents vs average claims per patent. Source: USPTO PatentsView.

Where Ses-imagotag's grants concentrate

SES-imagotag is a focused PatentsView assignee: 15 CPC subclasses with 41.9% of grants classified under G09G (Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information). Peak complete grant year is 2020 (6 grants) versus a trough of 2 in 2018. By volume, Ses-imagotag sits between Samyang Biopharmaceuticals Corporation and Siemens Energy AS.

Ses-imagotag's three-year grant acceleration

SES-imagotag shows 15 grants in 2022–2024 against only 14 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.

Who files at SES-imagotag's volume?

Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀

patents

What this shows SES-imagotag holds 31 patents at rank #10,167, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Source USPTO PatentsView, granted utility patents As of 2015–2025

Companies ranked near SES-imagotag

By rank, the assignees closest to #10,167 in granted patent volume.

Leaders in G09G (Arrangements OR Circuits FOR Control OF Indicating Device…)

Other assignees with the most granted patents in SES-imagotag's primary technology class.

Assignees with similar portfolio profiles

Two PlainPatent-derived peer sets for SES-imagotag, neither rank-band nor same-CPC leaders (those blocks stay above). In G09G (Arrangements OR Circuits FOR Control OF Indicating Device…), SES-imagotag ranks #255 of 1,688 assignees by patent count in that subclass.

Ses-imagotag's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

40 Top 37% higher than 63% of 49,997 US assignees

This assignee 0 100 every tracked assignee, bucketed by value

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

1234567 2018201920202021202220232024 6
USPTO utility patent grants by year · 2018–2024

Grants by year

Teal-shaded recent years (2020–present) versus the 2018–2019 baseline. Full figures in the table below.

View data table
SES-imagotag patent grants by year, 2015–2025
Year Patents Granted Share of Period
2018 2 6.5%
2019 5 16.1%
2020 6 19.4%
2021 3 9.7%
2022 3 9.7%
2023 6 19.4%
2024 6 19.4%

Which technologies does SES-imagotag patent most?

Top 15 of 15 technology areas

More on this record

Data Source

USPTO PatentsView, US granted patents 2015–2025

What to do with this data

SES-imagotag's patent record in context - here's where to go next.

  • SES-imagotag's lead technology class is G09G (Arrangements OR Circuits FOR Control OF Indicating Devices Using Static Means TO Present Variable Information), 41.9% of its portfolio - see every assignee active in that class. Explore G09G
  • Ranked #10,172 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
  • Compare SES-imagotag against Samyang Biopharmaceuticals Corporation, an assignee filing at a similar volume. Compare portfolios
  • Innovation Score of 39.8/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.